MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 116.65
(-1.69%)
EUR 116.65
(-1.69%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.63 Billion EUR | 0.11% |
| 2022 | 4.63 Billion EUR | 18.77% |
| 2021 | 3.9 Billion EUR | 18.4% |
| 2020 | 3.29 Billion EUR | -1.44% |
| 2019 | 3.34 Billion EUR | 20.91% |
| 2018 | 2.76 Billion EUR | 5.02% |
| 2017 | 2.63 Billion EUR | 0.96% |
| 2016 | 2.6 Billion EUR | -0.49% |
| 2015 | 2.61 Billion EUR | 57.85% |
| 2014 | 1.65 Billion EUR | 12.58% |
| 2013 | 1.47 Billion EUR | -3.89% |
| 2012 | 1.53 Billion EUR | -9.3% |
| 2011 | 1.69 Billion EUR | 1.05% |
| 2010 | 1.67 Billion EUR | 22.34% |
| 2009 | 1.36 Billion EUR | -2.81% |
| 2008 | 1.4 Billion EUR | 21.48% |
| 2007 | 1.15 Billion EUR | -4.91% |
| 2006 | 1.21 Billion EUR | 8.61% |
| 2005 | 1.12 Billion EUR | 9.63% |
| 2004 | 1.02 Billion EUR | -12.3% |
| 2003 | 1.16 Billion EUR | -2.29% |
| 2002 | 1.19 Billion EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 4.71 Billion EUR | -0.04% |
| 2024 Q1 | 4.71 Billion EUR | 1.7% |
| 2023 FY | 4.63 Billion EUR | 0.11% |
| 2023 Q4 | 4.63 Billion EUR | -6.72% |
| 2023 Q3 | 4.97 Billion EUR | -0.5% |
| 2023 Q1 | 4.89 Billion EUR | 5.57% |
| 2023 Q2 | 4.99 Billion EUR | 2.17% |
| 2022 Q3 | 4.86 Billion EUR | 8.63% |
| 2022 FY | 4.63 Billion EUR | 18.77% |
| 2022 Q2 | 4.47 Billion EUR | 7.99% |
| 2022 Q1 | 4.14 Billion EUR | 6.23% |
| 2022 Q4 | 4.63 Billion EUR | -4.69% |
| 2021 Q2 | 3.56 Billion EUR | 2.95% |
| 2021 Q4 | 3.9 Billion EUR | 3.72% |
| 2021 Q3 | 3.76 Billion EUR | 5.5% |
| 2021 FY | 3.9 Billion EUR | 18.4% |
| 2021 Q1 | 3.46 Billion EUR | 5.1% |
| 2020 Q2 | 3.53 Billion EUR | 2.73% |
| 2020 Q1 | 3.44 Billion EUR | 3.02% |
| 2020 Q3 | 3.42 Billion EUR | -3.08% |
| 2020 Q4 | 3.29 Billion EUR | -3.91% |
| 2020 FY | 3.29 Billion EUR | -1.44% |
| 2019 Q4 | 3.34 Billion EUR | 6.6% |
| 2019 Q1 | 2.93 Billion EUR | 6.26% |
| 2019 Q2 | 3.03 Billion EUR | 3.27% |
| 2019 Q3 | 3.13 Billion EUR | 3.36% |
| 2019 FY | 3.34 Billion EUR | 20.91% |
| 2018 FY | 2.76 Billion EUR | 5.02% |
| 2018 Q1 | 2.7 Billion EUR | 2.74% |
| 2018 Q2 | 2.7 Billion EUR | 0.15% |
| 2018 Q3 | 2.81 Billion EUR | 3.91% |
| 2018 Q4 | 2.76 Billion EUR | -1.78% |
| 2017 Q1 | 2.7 Billion EUR | 3.76% |
| 2017 Q4 | 2.63 Billion EUR | -2.37% |
| 2017 Q3 | 2.69 Billion EUR | -0.11% |
| 2017 Q2 | 2.69 Billion EUR | -0.22% |
| 2017 FY | 2.63 Billion EUR | 0.96% |
| 2016 Q4 | 2.6 Billion EUR | -0.53% |
| 2016 Q3 | 2.62 Billion EUR | -0.72% |
| 2016 Q2 | 2.64 Billion EUR | 1.42% |
| 2016 FY | 2.6 Billion EUR | -0.49% |
| 2016 Q1 | 2.6 Billion EUR | -0.64% |
| 2015 Q2 | 1.79 Billion EUR | -1.18% |
| 2015 Q3 | 1.79 Billion EUR | 0.12% |
| 2015 Q1 | 1.81 Billion EUR | 9.35% |
| 2015 FY | 2.61 Billion EUR | 57.85% |
| 2015 Q4 | 2.61 Billion EUR | 45.9% |
| 2014 FY | 1.65 Billion EUR | 12.58% |
| 2014 Q2 | 1.61 Billion EUR | 7.08% |
| 2014 Q1 | 1.51 Billion EUR | 2.54% |
| 2014 Q4 | 1.65 Billion EUR | 0.22% |
| 2014 Q3 | 1.65 Billion EUR | 2.3% |
| 2013 Q1 | 1.55 Billion EUR | 1.66% |
| 2013 FY | 1.47 Billion EUR | -3.89% |
| 2013 Q4 | 1.47 Billion EUR | -5.84% |
| 2013 Q3 | 1.56 Billion EUR | 2.13% |
| 2013 Q2 | 1.53 Billion EUR | -1.69% |
| 2012 Q3 | 1.6 Billion EUR | -3.48% |
| 2012 Q4 | 1.53 Billion EUR | -4.7% |
| 2012 FY | 1.53 Billion EUR | -9.3% |
| 2012 Q1 | 1.65 Billion EUR | -1.9% |
| 2012 Q2 | 1.66 Billion EUR | 0.52% |
| 2011 Q3 | 1.69 Billion EUR | 2.77% |
| 2011 FY | 1.69 Billion EUR | 1.05% |
| 2011 Q1 | 1.68 Billion EUR | 0.81% |
| 2011 Q2 | 1.64 Billion EUR | -2.5% |
| 2011 Q4 | 1.69 Billion EUR | 0.04% |
| 2010 Q2 | 1.53 Billion EUR | 7.86% |
| 2010 Q1 | 1.42 Billion EUR | 4.27% |
| 2010 FY | 1.67 Billion EUR | 22.34% |
| 2010 Q4 | 1.67 Billion EUR | -5.64% |
| 2010 Q3 | 1.77 Billion EUR | 15.28% |
| 2009 FY | 1.36 Billion EUR | -2.81% |
| 2009 Q4 | 1.36 Billion EUR | 0.0% |
| 2008 FY | 1.4 Billion EUR | 21.48% |
| 2007 FY | 1.15 Billion EUR | -4.91% |
| 2006 FY | 1.21 Billion EUR | 8.61% |
| 2005 FY | 1.12 Billion EUR | 9.63% |
| 2004 FY | 1.02 Billion EUR | -12.3% |
| 2003 FY | 1.16 Billion EUR | -2.29% |
| 2002 FY | 1.19 Billion EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| MPH Health Care AG | - EUR | -Infinity% |
| Apontis Pharma AG | 6.6 Million EUR | -70157.576% |
| Dermapharm Holding SE | 320.75 Million EUR | -1345.638% |
| Evotec SE | 30.89 Million EUR | -14911.331% |
| PharmaSGP Holding SE | 10.11 Million EUR | -45733.745% |
| SynBiotic SE | 2.76 Million EUR | -167627.882% |